Henry Schein Intrinsic Stock Value – Henry Schein Shares Rise 3.11% Amid Positive Trading Session for Stock Market
April 4, 2024
☀️Trending News
Henry Schein ($NASDAQ:HSIC) Inc. is a leading provider of health care products and services to medical, dental, and veterinary professionals around the world. On Wednesday, Henry Schein’s shares saw a 3.11% increase, reaching $75.15. This was part of an overall positive trading session for the stock market, with the company performing well across the board. The rise in stock price can be attributed to several factors, including strong financial performance, positive industry outlook, and investor confidence. One of the main reasons for Henry Schein’s success is its consistent financial performance. This solid growth demonstrates the company’s ability to effectively navigate through challenging market conditions and deliver strong results. In addition to its financial performance, the healthcare industry as a whole is experiencing positive growth and outlook. With an aging population and increasing demand for healthcare services, companies like Henry Schein are well-positioned to capitalize on this trend.
The company offers a wide range of products and services in the medical, dental, and veterinary fields, making it a one-stop-shop for healthcare professionals. Investor confidence is also a key factor in Henry Schein’s rising stock price. As one of the top-performing stocks in the healthcare industry, the company has attracted the attention of investors looking for stable and profitable investments. With a strong track record of delivering value to shareholders, Henry Schein has become a favored choice among investors. In conclusion, Henry Schein’s shares saw a 3.11% increase amid a positive trading session for the stock market. The company’s strong financial performance, positive industry outlook, and investor confidence have all contributed to its success. As the healthcare industry continues to grow, Henry Schein is well-positioned to maintain its position as a leader in the market and deliver strong returns to its investors.
Analysis – Henry Schein Intrinsic Stock Value
As part of my analysis, I have thoroughly examined HENRY SCHEIN‘s fundamentals. This includes looking at their financial statements, market trends, and competitive landscape. Based on my findings, I have determined that the intrinsic value of HENRY SCHEIN’s shares is approximately $83.8. This value is calculated using our proprietary Valuation Line, which takes into account various factors such as earnings, dividends, and growth potential. This indicates that the stock is undervalued by approximately 10.0%, making it a potentially attractive investment opportunity. With the stock being undervalued, there is potential for it to increase in value over time, providing investors with a solid return on their investment. One of the main reasons for HENRY SCHEIN’s undervaluation may be due to market factors or short-term fluctuations. However, my analysis of the company’s fundamentals shows that it is a strong and stable company with a solid financial standing. This suggests that the current stock price does not accurately reflect the true value of the company. In conclusion, based on my analysis, I believe that HENRY SCHEIN’s stock is currently trading at a fair price that is undervalued by 10.0%. This presents a potential opportunity for investors to purchase shares at a lower price and potentially see a significant return on their investment in the future. As always, it is important for investors to conduct their own thorough research and due diligence before making any investment decisions. More…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Henry Schein. More…
| Total Revenues | Net Income | Net Margin |
| 12.34k | 416 | 3.9% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Henry Schein. More…
| Operations | Investing | Financing |
| 500 | -1.14k | 701 |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Henry Schein. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 10.57k | 5.42k | 28.28 |
Key Ratios Snapshot
Some of the financial key ratios for Henry Schein are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 6.8% | 7.0% | 5.1% |
| FCF Margin | ROE | ROA |
| 2.5% | 10.8% | 3.7% |
Peers
Henry Schein Inc is one of the largest companies in the dental supplies industry.
However, it faces stiff competition from Healthlead PCL, Patterson Companies Inc, and Alfresa Holdings Corp. All four companies are large, international players in the dental supplies industry.
– Healthlead PCL ($SET:HL)
LeadPCL is a Thailand-based company engaged in the manufacture and sale of lead products. The Company offers lead ingots, lead sheets, lead pipes, lead wires, lead oxides and other lead products. It also provides lead recycling services. The Company’s products are used in a range of applications, including in the automotive, electronics, construction and medical industries.
– Patterson Companies Inc ($NASDAQ:PDCO)
Patterson Companies Inc is a leading provider of animal health and dental products and services. The company has a market cap of 2.61B as of 2022 and a return on equity of 16.53%. Patterson Companies Inc operates in the United States, Canada, and Europe. The company’s products and services include veterinary supplies, dental supplies, and diagnostic imaging. Patterson Companies Inc is headquartered in Minneapolis, Minnesota.
– Alfresa Holdings Corp ($TSE:2784)
Alfresa Holdings Corp is a Japanese pharmaceutical and medical equipment company with a market cap of 280.99B as of 2022. The company has a Return on Equity of 6.23%. Alfresa Holdings Corp is engaged in the research, development, manufacture, and sale of pharmaceuticals and medical equipment. The company’s products include drugs for the treatment of cancer, infectious diseases, and cardiovascular diseases; and medical devices for use in surgery, diagnosis, and treatment.
Summary
Shares of Henry Schein Inc. had a positive trading session on Wednesday, with a 3.11% increase to $75.15. This rise was part of an overall trend of favorable market conditions for the stock market. The company’s stock performance is likely being driven by strong investing analysis and positive investor sentiment.
While further details about Henry Schein’s specific financials or operations are not provided, it can be assumed that the company is attracting investors due to its solid financial performance and promising outlook. With a strong uptick in share price, Henry Schein appears to be a promising investment option for those looking to gain exposure to the health care industry.
